Episode Details
Back to Episodes335: A deep dive on Makary, Vertex's pain data, & 2025 predictions
Published 1 year, 10 months ago
Description
STAT's FDA reporter Lizzy Lawrence joins us to discuss her profile of Marty Makary, Trump's nominee for FDA commissioner. Then, we discuss the results of Vertex's latest pain drug trial, the medication launches to watch in 2025, and present our burning questions for the biopharma industry.